DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma

Bibliographic Details
Title: DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma
Authors: Kirk, Allison M., Crawford, Jeremy Chase, Chou, Ching-Heng, Guy, Cliff, Pandey, Kirti, Kozlik, Tanya, Shah, Ravi K., Chung, Shanzou, Nguyen, Phuong, Zhang, Xiaoyu, Wang, Jin, Bell, Matthew, Mettelman, Robert C., Allen, E. Kaitlynn, Pogorelyy, Mikhail V., Kim, Hyunjin, Minervina, Anastasia A., Awad, Walid, Bajracharya, Resha, White, Toni, Long, Donald, Jr., Gordon, Brittney, Morrison, Michelle, Glazer, Evan S., Murphy, Andrew J., Jiang, Yixing, Fitzpatrick, Elizabeth A., Yarchoan, Mark, Sethupathy, Praveen, Croft, Nathan P., Purcell, Anthony W., Federico, Sara M., Stewart, Elizabeth, Gottschalk, Stephen, Zamora, Anthony E., DeRenzo, Christopher, Strome, Scott E., Thomas, Paul G.
Source: In Cell Reports Medicine 19 March 2024 5(3)
Database: ScienceDirect
More Details
ISSN:26663791
DOI:10.1016/j.xcrm.2024.101469
Published in:Cell Reports Medicine
Language:English